| Literature DB >> 28099195 |
Amir M Benmira1, Antonia Perez-Martin, Sarah Coudray, Iris Schuster, Isabelle Aichoun, Jérémy Laurent, Fethi Bereski-Reguig, Michel Dauzat.
Abstract
BACKGROUND: Noninvasive blood pressure (BP) measurement is essential for the study of human physiology but automatic oscillometric devices only estimate SBP and DBP using various, undisclosed algorithms, precluding standardization and interchangeability. We propose a novel approach by tracking, during pneumatic cuff deflation, the time interval from the foot to the apex of the systolic peak of the oscillometric signal, which reaches a maximum concomitant with the first Korotkoff sound.Entities:
Mesh:
Year: 2017 PMID: 28099195 PMCID: PMC5378056 DOI: 10.1097/HJH.0000000000001252
Source DB: PubMed Journal: J Hypertens ISSN: 0263-6352 Impact factor: 4.844
FIGURE 1Korotkoff sounds, oscillometric pulse pressure waveform, and systolic peak foot-to-apex time interval (tf-a) changes during cuff deflation (from study participant #46). (a) Changes in tf-a at the appearance of Korotkoff sounds. (b): The Korotkoff sounds, the oscillometric pulse pressure waveform, the tf-a curve, and the cuff pressure during deflation. SBP is measured at the time of the first tf-a maximum. tf-a, time from the foot to the apex of the oscillometric waveform systolic peak.
Population sample description
| Whole population sample | No cardiovascular risk factor | One cardiovascular risk factor | >1 cardiovascular risk factor | |
| 145 | 53 | 51 | 41 | |
| Sex ratio (M/F) | 68/77 | 24/29 | 25/26 | 19/22 |
| Age (years) | 18–88; 45 (27–59) | 21–62; 29 (25–47) | 18–88; 49 (34.5–60.5) | 18–83; 58 (41–71) |
| BMI (kg/m2) | 15.3–56.0; 24.2 (21.4–26.5) | 16.8–36.7; 22.5 (20.1–25.0) | 15.3–41.5; 25.7 (22.0–27.4) | 17.1–56.0; 25.1 (22.1–28.1) |
| SBPosc (mmHg) | 62–223; 117 (110–133) | 98–139; 113 (107–121) | 90–223; 121 (111–143) | 62–215; 125 (117–148) |
| DBPosc (mmHg) | 37–108; 73 (66–81) | 53–86; 71 (66–77) | 54–104; 74 (65–84) | 37–108; 78 (69–87) |
| MBPosc (mmHg) | 42–139; 93 (77–93) | 67–92; 82 (74–87) | 61–139; 87 (79–98) | 42–131; 93.5 (83–108) |
SBPosc, DBPosc, MBPosc, SBP, DBP, and mean systemic arterial blood pressure measurement by conventional oscillometry on the right arm. Results are provided as range and median (first to third quartile).
SBP measured by conventional oscillometry, SBP measured by the auscultation technique, and arm cuff pressure corresponding to the first maximum of the systolic peak foot-to-apex time interval values of brachial artery SBP in the whole population sample
| Right arm | Left arm | |||||
| Pad1 | SBPK | SBPosc | Pad1 | SBPK | SBPosc | |
| Maximum | 217.0 | 221.0 | 223.0 | 190.0 | 187.0 | 215.0 |
| 75% percentile | 137.0 | 136.0 | 133.0 | 135.0 | 136 | 136.0 |
| Median | 119.0 | 119.0 | 117.5 | 118.0 | 118.0 | 116.0 |
| 25% percentile | 107.0 | 109.0 | 109.8 | 105.0 | 105 | 107.0 |
| Minimum | 64.0 | 64.0 | 62.0 | 89.0 | 85.0 | 68.0 |
| 140 | 139 | 138 | 132 | 133 | 133 | |
Pad1, arm cuff pressure corresponding to the first maximum of the systolic peak foot-to-apex time interval; SBPK, SBP measured by automatic reading of Korotkoff sounds; SBPosc, SBP measured by conventional oscillometry.
FIGURE 2Bland and Altman plot of SBP measurement by the different techniques (right arm). (a) Systolic peak apex delay technique (Pad1) vs. automatic reading of Korotkoff sounds (SBPK). (b) Oscillometry (SBPIA) vs. automatic reading of Korotkoff sounds (SBPK). (c) Pad1 vs. oscillometry (SBPIA). (d) Pad1 vs. direct intra-arterial measurement (SBPIA). Pad1, arm-cuff pressure corresponding to the first maximum of the systolic peak foot-to-apex time interval; SBP measured by radial artery catheter; SBPK, SBP measured by the auscultation technique.
Correlations between SBP measured by conventional oscillometry, SBP measured by the auscultation technique, and arm cuff pressure corresponding to the first maximum of the systolic peak foot-to-apex time interval values of SBP
| Comparison | Lin CCC ρc | Two-sided 95% confidence interval | Pearson | Bias (95% limits of agreement) |
| Whole population sample ( | ||||
| Right side | ||||
| Pad1 vs. SBPK | 0.984 | 0.977–0.988 | 0.969 | 0.83 (−7.60 to 9.26) |
| SBPosc vs. SBPK | 0.917 | 0.886–0.940 | 0.844 | 0.90 (−17.62 to 19.41) |
| Pad1 vs. SBPosc | 0.919 | 0.888–0.941 | 0.847 | −0.07 (−18.83 to 18.68) |
| Left side | ||||
| Pad1 vs. SBPK | 0.989 | 0.985–0.992 | 0.980 | −0.30 (−6.24 to 6.85) |
| SBPosc vs. SBPK | 0.884 | 0.841–0.916 | 0.784 | −0.64 (−20.80 to 22.09) |
| PPad1 vs. SBPosc | 0.882 | 0.837–0.915 | 0.776 | −0.37 (−22.45 to 21.72) |
| Study participants without cardiovascular risk factor ( | ||||
| Right side | ||||
| Pad1 vs. SBPK | 0.939 | 0.899–0.964 | 0.910 | 1.89 (−4.81 to 8.59) |
| SBPosc vs. SBPK | 0.755 | 0.613–0.850 | 0.585 | −1.53 (−16.34 to 13.28) |
| Pad1 vs. SBPosc | 0.750 | 0.611–0.844 | 0.622 | 3.42 (−10.26 to 17.09) |
| Left side | ||||
| Pad1 vs. SBPK | 0.953 | 0.921–0.972 | 0.916 | 0.85 (−6.57 to 8.27) |
| SBPosc vs. SBPK | 0.654 | 0.467–0.785 | 0.438 | −1.33 (−20.29 to 17.63) |
| Pad1 vs. SBPosc | 0.638 | 0.450–0.772 | 0.427 | 2.12 (−17.85 to 22.08) |
| Study participants with one cardiovascular risk factor ( | ||||
| Right side | ||||
| Pad1 vs. SBPK | 0.984 | 0.973–0.990 | 0.973 | −0.24 (−8.75 to 8.27) |
| SBPosc vs. SBPK | 0.892 | 0.819–0.936 | 0.806 | −1.16 (−20.86 to 23.19) |
| Pad1 vs. SBPosc | 0.896 | 0.823–0.940 | 0.806 | −1.43 (−23.76 to 20.90) |
| Left side | ||||
| Pad1 vs. SBPK | 0.991 | 0.984–0.995 | 0.984 | −0.18 (−6.88 to 6.53) |
| SBPosc vs. SBPK | 0.933 | 0.886–0.962 | 0.890 | 2.38 (−15.70 to 20.45) |
| Pad1 vs. SBPosc | 0.936 | 0.887–0.964 | 0.886 | −2.56 (−20.78 to 15.67) |
| Study participants with more than one cardiovascular risk factor ( | ||||
| Right side | ||||
| Pad1 vs. SBPK | 0.985 | 0.972–0.992 | 0.972 | −0.75 (−9.23 to 10.73) |
| SBPosc vs. SBPK | 0.947 | 0.904–0.972 | 0.925 | −4.11 (−12.47 to 20.69) |
| Pad1 vs. SBPosc | 0.947 | 0.901–0.972 | 0.915 | −3.36 (−20.43 to 13.71) |
| Left side | ||||
| Pad1 vs. SBPK | 0.995 | 0.991–0.997 | 0.990 | 0.11 (−4.49 to 4.72) |
| SBPosc vs. SBPK | 0.834 | 0.702–0.911 | 0.705 | 1.28 (−26.26 to 28.82) |
| Pad1 vs. SBPosc | 0.829 | 0.691–0.909 | 0.696 | −1.17 (−29.21 to 26.87) |
LinCCC, concordance correlation coefficient; Pad1, SBP measured by the systolic peak foot-to-apex time interval technique; SBPK, SBP measured by automatic reading of Korotkoff sounds; SBPosc, SBP measured by conventional oscillometry.
Foot-to-apex time interval time at which the systolic peak apex delay reaches it first maximum depending on the number of cardiovascular risk factors
| Number of cardiovascular risk factors | tf-a (ms) right arm | tf-a (ms) left arm |
| Any | 124 (115–215) | 126 (115–200) |
| None | 118 (111–125) | 121 (114–126) |
| One | 154 (115–234) | 149 (114–228) |
| More than one | 175 (118–234) | 167 (124–227) |
Results are provided as median (lower–upper quartile).
tf-a, systolic peak foot-to-apex time interval.
FIGURE 3Age of study participants without or with a second increase of the tf-a. Box and whiskers plots (the box limits are first to third percentile; the horizontal line is the median, the whiskers cover the range). tf-a, time from the foot to the apex of the oscillometric waveform systolic peak.
Comparison between arm-cuff pressure corresponding to the first maximum of the systolic peak foot-to-apex time interval, SBP measured by radial artery catheter, and SBP measured by the auscultation technique in ICU patients (n = 35)
| Comparison | ρc | Pearson | 95% CI | Bias (95% limits of agreement) | Difference (mmHg) Mean ± SD |
| Pad1 vs. SBPIA | 0.72 (0.54–0.84) | 0.80 | 0.64–0.89 | −9.94 (−38.0 to 18.1) | −9.9 ± 14.3 |
| SBPK vs. SBPIA | 0.67 (0.47–0.80) | 0.77 | 0.58–0.87 | −12.2 (−42.9 to 18.5) | 12.2 ± 15.7 |
| Pad1 vs. SBPK | 0.92 (0.85–0.96) | 0.93 | 0.86–0.96 | −2.26 (−14.2 to18.7) | 2.3 ± 8.4 |
CI, confidence interval; Pad1, arm-cuff pressure corresponding to the first maximum of the systolic peak foot-to-apex time interval; SBPIA, SBP measured by radial artery catheter; SBPK, SBP measured by the auscultation technique; ρc, Lin CCC: Lin concordance correlation coefficient (lower and upper two-sided CI).